Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
46 hedge funds and large institutions have $212M invested in Lucira Health, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 10 closing their positions.
35,443% more call options, than puts
Call options by funds: $2.49M | Put options by funds: $7K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
100% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 10
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
60% more capital invested
Capital invested by funds: $132M → $212M (+$79.8M)
28% more funds holding
Funds holding: 36 → 46 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.87M |
| 2 |
Millennium Management
New York
|
+$1.43M |
| 3 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$1.27M |
| 4 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$1.17M |
| 5 |
PVI
Pura Vida Investments
New York
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$4.39M |
| 2 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$946K |
| 3 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
-$760K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$710K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$438K |
LHDX Hedge Fund Activity: Q4 2021 in Review
46 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q4 2021, worth a combined $212M — up 60% from $132M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new LHDX positions and 10 closed out — a net gain of 10 holders — while 12 added to existing stakes and 7 trimmed.
The largest buyer was Silverarc Capital Management, adding an estimated $1.87M. The largest seller was MPM BioImpact, exiting entirely with an estimated $4.39M sold.
- 46 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q4 2021, up from 36 in Q3 2021.
- Funds reported $212M of Lucira Health, Inc. Common Stock stock for Q4 2021, up 60% quarter-over-quarter.
- 20 funds opened new Lucira Health, Inc. Common Stock positions in Q4 2021 and 10 closed out, a net change of +10 holders.
- The largest Lucira Health, Inc. Common Stock buyer in Q4 2021 was Silverarc Capital Management, an estimated $1.87M added.
- The largest Lucira Health, Inc. Common Stock seller in Q4 2021 was MPM BioImpact, an estimated $4.39M sold.
Based on aggregated 13F filings for Q4 2021.